Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer

被引：0
|
作者：
Liu, Bo [1 ]
Drago, Joshua Z. [1 ]
Rao, Yi [1 ]
Pereira, Patricia R. [2 ]
Safonov, Anton [1 ]
Marra, Antonio [1 ]
Ahmed, Mehnaj S. [1 ]
Modi, Shanu [1 ]
Reis-Filho, Jorge S. [1 ]
Montemurro, Filippo [3 ]
Razavi, Pedram [1 ]
Lewis, Jason S. [1 ]
Chandarlapaty, Sarat [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Candiolo Canc Inst, Turin, Italy
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1787
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Antibody-drug conjugates for cancer therapy
    Thomas, Anish
    Teicher, Beverly A.
    Hassan, Raffi T.
    LANCET ONCOLOGY, 2016, 17 (06): : E254 - E262
  • [22] Antibody-Drug Conjugates in Cancer Therapy
    Sievers, Eric L.
    Senter, Peter D.
    ANNUAL REVIEW OF MEDICINE, VOL 64, 2013, 64 : 15 - 29
  • [23] Impacts of genomic alterations on the efficacy of HER2-targeted antibody-drug conjugates in patients with metastatic breast cancer
    Huang, Riqing
    Hu, Anqi
    Rong, Qixiang
    Shu, Ditian
    Chen, Meiting
    Yang, Wei
    Zhang, Yue
    Zheng, Qiufan
    An, Xin
    Xue, Cong
    Li, Haifeng
    Shi, Yanxia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [24] Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer
    Rassy, Elie
    Rached, Layal
    Pistilli, Barbara
    BREAST, 2022, 66 : 217 - 226
  • [25] Antibody-drug Conjugates for Breast Cancer Treatment
    Sheikh, M. Saeed
    Huang, Ying
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (02) : 108 - 113
  • [26] Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer
    Saleh, Khalil
    Khoury, Rita
    Khalife, Nadine
    Chahine, Claude
    Ibrahim, Rebecca
    Tikriti, Zamzam
    Le Cesne, Axel
    CANCER DRUG RESISTANCE, 2024, 7 : 2 - 15
  • [27] Current and Emerging Role of Antibody-Drug Conjugates in HER2-Negative Breast Cancer
    Abelman, Rachel Occhiogrosso
    Keenan, Jennifer C.
    Ryan, Phoebe K.
    Spring, Laura M.
    Bardia, Aditya
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 151 - 167
  • [28] Antibody-Drug Conjugates for the Treatment of Breast Cancer
    Corti, Chiara
    Giugliano, Federica
    Nicolo, Eleonora
    Ascione, Liliana
    Curigliano, Giuseppe
    CANCERS, 2021, 13 (12)
  • [29] Update on Antibody-Drug Conjugates in Breast Cancer
    Rugo, Hope S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 148 - 151
  • [30] Next-Generation HER2-Targeted Antibody-Drug Conjugates in Breast Cancer
    Zimmerman, Brittney S.
    Esteva, Francisco J.
    CANCERS, 2024, 16 (04)
12345